| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $37K | -31.5% | +311.1% |
| Gross Profit | -$34.2M | -27.4% | -59.6% |
| R&D Expense | $6.6M | +32.7% | +28.2% |
| SG&A Expense | $19.7M | +39.7% | +137.9% |
| Operating Income | -$206.8M | -329.9% | -720.4% |
| Pre-tax Income | -$222.2M | -78.2% | -186.0% |
| Income Tax | $5K |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $62.9M | +375.6% | +765.4% |
| Accounts Receivable | $589K | -8.7% | — |
| Inventory | $381K | -98.4% | -98.6% |
| Current Assets | $90.0M | +17.6% | +13.0% |
| Total Assets | $315.6M | -21.0% | -29.7% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$79.2M | — | — |
| Capital Expenditures | $6.5M | — | — |
| Investing Cash Flow | $277K | — | — |
| Financing Cash Flow | $135.8M | — | — |
| Free Cash Flow | -$85.7M | — | — |
| — |
| +600.0% |
| Net Income | -$222.2M | -78.2% | -186.0% |
| $211.2M |
| -5.1% |
| -14.8% |
| Total Liabilities | $355.1M | +4.5% | +21.5% |
| Stockholders' Equity | -$77.7M | -229.9% | -149.6% |